article
math_shortcuts Background: It is estimated that 214 million women of reproductive age have an unmet need for contraception in many developing countries including Nigeria. Some reasons attributed to this are: limited access to contraception, fear or experience of side-effects, cultural or religious reasons. This study evaluated the perception and utilization of contraceptive among women of reproductive age group in Kafin Madaki Community, Bauchi State, Northeast Nigeria. Methods: It was a prospective cross-sectional study. A semi-structured questionnaire was used to obtain necessary information from the respondents. Data analysis was performed using SPSS version 25. Results: The current contraceptive prevalence rate (CPR) was 38%. Majority of the respondents have a positive perception towards the use of contraceptive 84.1%. The factors positively and significantly associated with contraceptive use are: Parity (OR=5.69; 95% CI=4.69 – 6.69), healthcare workers as source of information on contraceptive (OR=6.16; CI=3.02–12.57), positive perception towards use of contraceptives (OR=6.37; 95% CI=1.98 – 20.54), and fear of side effects (OR=4.54; CI=2.33 – 8.84). The factors negatively and significantly associated with contraceptive use are: families as source of information on contraceptive (OR=0.16; CI=0.07–0.03), being desirous of pregnancy (OR=0.13; 95% CI=0.07 – 0.25), and unavailability of contraceptives (OR=0.07; 95% CI=0.03 – 0.19). Conclusion: The CPR in this study is within the National 2020 target but far below the WHO recommended global target. Most women have a positive perception towards contraceptive use. However, unavailability and lack of access to contraceptives is a significant factor precluding its use in the community.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.22541/au.177258982.25133670/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.